| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1997;114:339-346
© 1997 Mosby, Inc.
GENERAL THORACIC SURGERY |
Supported by a grant-in-aid (07457300) from the Ministry of Education, Science, and Culture in Japan.
Received for publication Sept. 24, 1996; revisions requested Nov. 11, 1996; revisions received March 10, 1997; accepted for publication March 11, 1997. Address for reprints: Kazuhito Dobashi, MD, Department of Surgery II, School of Medicine, University of Occupational and Environmental Health, Iseigaoka 1-1, Yahatanishi-ku, Kitakyushu 807, Japan.
Abstract
Objectives: Approximately one fourth of all patients with stage I non-small-cell lung cancer die of tumor recurrence, despite radical removal of their tumors. We thus tried to detect micrometastasis in the regional lymph nodes indicated to be tumor free by conventional histopathologic methods in patients with non-small-cell lung cancer by using immunohistochemical staining for p53 protein. We also investigated the relation between micrometastatic p53-positive cells in the lymph nodes and the prognosis of the patients. Methods: Samples from 480 regional lymph nodes were taken from 47 patients who underwent pulmonary resection for non-small-cell lung cancer and whose primary lesions were positive for p53 immunohistochemical staining. These samples were fixed in formalin and embedded in paraffin. We used p53 immunohistochemical staining to detect micrometastatic tumor cells in the lymph nodes. Results: Cells positive for p53 protein were found in 14 of 31 (45%) patients with a negative pathologic lymph node status and in 26 of 315 (8.3%) lymph nodes in these patients. The proportion of patients with micrometastasis who survived was also significantly lower than the proportion of patients without micrometastasis who survived (p = 0.0001). Conclusions: Immunohistochemical staining for the p53 protein offers a rapid, sensitive, and useful way of detecting for micrometastasis to the regional lymph nodes in patients with non-small-cell lung cancer that is positive for p53 staining. The patients with such micrometastasis have a poor prognosis and thus need to be carefully followed up after the initial pulmonary resection.
This article has been cited by other articles:
|
|
 |
|
  K. Sugi, S. Kobayashi, R. Yagi, and T. Matsuoka Usefulness of sentinel lymph node biopsy for the detection of lymph node micrometastasis in early lung cancer Interactive CardioVascular and Thoracic Surgery, October 1, 2008; 7(5): 913 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Jeremic Low Incidence of Isolated Nodal Failures After Involved-Field Radiation Therapy for Non Small-Cell Lung Cancer: Blinded by the Light? J. Clin. Oncol., December 10, 2007; 25(35): 5543 - 5545. [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Park, C.-T. Lee, H. W. Lee, H. J. Baek, J. I. Zo, and Y. M. Shim Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 1086 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Wallace, M. I. Block, W. Gillanders, J. Ravenel, B. J. Hoffman, C. E. Reed, M. Fraig, D. Cole, and M. Mitas Accurate Molecular Detection of Non-small Cell Lung Cancer Metastases in Mediastinal Lymph Nodes Sampled by Endoscopic Ultrasound-Guided Needle Aspiration Chest, February 1, 2005; 127(2): 430 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Xi, J. D. Luketich, S. Raja, W. E. Gooding, V. R. Litle, M. C. Coello, S. D. Finkelstein, M. L. Chestney, R. J. Landreneau, S. J. Hughes, et al. Molecular Staging of Lymph Nodes from Patients with Esophageal Adenocarcinoma Clin. Cancer Res., February 1, 2005; 11(3): 1099 - 1109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Uramoto, K. Sugio, T. Oyama, S. Nakata, K. Ono, M. Morita, K. Funa, and K. Yasumoto Expression of {Delta}Np73 Predicts Poor Prognosis in Lung Cancer Clin. Cancer Res., October 15, 2004; 10(20): 6905 - 6911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. Hollaus, P. N. Wurnig, and N. S. Pridun The natural history of recurrence after bronchoplastic procedures for non-small cell lung cancer Ann. Thorac. Surg., August 1, 2003; 76(2): 363 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yasumoto, T. Osaki, Y. Watanabe, H. Kato, and T. Yoshimura Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study Ann. Thorac. Surg., July 1, 2003; 76(1): 194 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Wallace, M. Block, B. J. Hoffman, R. H. Hawes, G. Silvestri, C. E. Reed, M. Mitas, J. Ravenel, M. Fraig, S. Miller, et al. Detection of Telomerase Expression in Mediastinal Lymph Nodes of Patients with Lung Cancer Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1670 - 1675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kara, E. Dikmen, D. Kilic, S. Dizbay Sak, D. Orhan, S. K. Kose, and S. Kavukcu Prognostic implications of microscopic proximal bronchial extension in non-small cell lung cancer Ann. Thorac. Surg., August 1, 2002; 74(2): 348 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Jiao and M. J. Krasna Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology Ann. Thorac. Surg., July 1, 2002; 74(1): 278 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Osaki, T. Oyama, C.-D. Gu, T. Yamashita, T. So, M. Takenoyama, K. Sugio, and K. Yasumoto Prognostic Impact of Micrometastatic Tumor Cells in the Lymph Nodes and Bone Marrow of Patients With Completely Resected Stage I Non-Small-Cell Lung Cancer J. Clin. Oncol., July 1, 2002; 20(13): 2930 - 2936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Passlick, B. Kubuschock, W. Sienel, O. Thetter, K. Pantel, and J.R. Izbicki Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases -- results of a preliminary study Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 520 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Ahrendt, S. C. Yang, L. Wu, C. M. Roig, P. Russell, W. H. Westra, J. Jen, M. V. Brock, R. F. Heitmiller, and D. Sidransky Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: Preliminary results of a prospective study J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 466 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Steels, M. Paesmans, T. Berghmans, F. Branle, F. Lemaitre, C. Mascaux, A.P. Meert, F. Vallot, J.J. Lafitte, and J.P. Sculier Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis Eur. Respir. J., October 1, 2001; 18(4): 705 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.J. Poncelet, B. Weynand, F. Ferdin, A.R. Robert, and P.H. Noirhomme Bone marrow micrometastasis might not be a short-term predictor of survival in early stages non-small cell lung carcinoma Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 481 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.W. A. Oosterhuis, P. H.M.H. Theunissen, and E. C.M. Bollen Improved pre-operative mediastinal staging in non-small-cell lung cancer by serial sectioning and immunohistochemical staining of lymph-node biopsies Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 335 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Mineo, V. Ambrogi, V. Corsaro, and M. Roselli Postoperative adjuvant therapy for stage IB non-small-cell lung cancer Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 378 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wu, Y. Ohta, H. Minato, Y. Tsunezuka, M. Oda, Y. Watanabe, and G. Watanabe Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter Ann. Thorac. Surg., June 1, 2001; 71(6): 1772 - 1777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hashimoto, Y. Kobayashi, Y. Ishikawa, S. Tsuchiya, S. Okumura, K. Nakagawa, Y. Tokuchi, M. Hayashi, K. Nishida, S.-i. Hayashi, et al. Prognostic Value of Genetically Diagnosed Lymph Node Micrometastasis in Non-Small Cell Lung Carcinoma Cases Cancer Res., November 1, 2000; 60(22): 6472 - 6478. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. A. Farrell, H. P. McAdams, J. E. Herndon, and E. F. Patz Jr Non-Small Cell Lung Cancer: FDG PET for Nodal Staging in Patients with Stage I Disease Radiology, June 1, 2000; 215(3): 886 - 890. [Abstract] [Full Text]
|
|
|
|
|
|
I. Yoshino, R. Nakanishi, T. Osaki, M. Takenoyama, S. Taga, T. Hanagiri, and K. Yasumoto Unfavorable Prognosis of Patients With Stage II Non-small Cell Lung Cancer Associated With Macroscopic Nodal Metastases Chest, July 1, 1999; 116(1): 144 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Offner, W. Schmaus, K. Witter, G. B. Baretton, G. Schlimok, B. Passlick, G. Riethmuller, and K. Pantel p53 gene mutations are not required for early dissemination of cancer cells PNAS, June 8, 1999; 96(12): 6942 - 6946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Brandwein and D. Y. Zhang "Molecular Margins": A Better Measure? Arch Otolaryngol Head Neck Surg, August 1, 1998; 124(8): 841 - 842. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
